Conjugates of haptens to beta-lactam derivatives and their use for detecting and/or quantifying haptens in solution and device for implementation thereof
EP0897540A1
Method for detecting and/or quantifying a hapten in a homogeneous phase and device for implementation thereof
MX9701283A
Compounds, pharmaceutical composition and diagnostic device comprising same and their use.
BE1008581A3
Pro-drugs, pharmaceutical formulation comprising said pro-drugs and usethereof
EP0662154A1
Conjugate for the detection and/or assay of a biological compound
US5846799A
Human myeloperoxidase and its therapeutic application
5 '(oh) and / or 3' (oh) chemically modified nucleic acid probes for the introduction in these positions of one or more non-radioactive labeling elements and preparation method.
US5460961A
Human myeloperoxidase and its therapeutic application
BE1004560A3
Basic thermoplastic products for the production of continuous fibrereinforced thermoplastic plates, sheets or tubes
BE1003705A3
Pricing system and proportional perception in transportation.
EP0365421A1
Specific ligands for estrogenic and progestagenic steroidal hormone receptors, their use and synthesis intermediates
EP0372063A1
Human myeloperoxydasis and its therapeutic application
EP0208672A1
Vaccines and diagnostics derived from bovine diarrhea virus
BE901119A
Process for the preparation of vector plasmids capable of transforming a bacterial host escherichia coli and of promoting and controlling the expression of heterologous dna in it.
BE900679A
Process for the enzymatic hydrolysis of aqueous inulin solutions.
BE900159A
Anaerobic purificn. of liq. effluent in fluidised bed reactor - with two liq. recycling circuits of which one assists fluidisation
BE899531A
Sulfide hydantoin derivatives and pharmaceutical compositions containing them.
ZA8401033B
Method for the preparation of a bacterial clone which produces human alpha1-antitrypsin,cdna encoding human alpha1-antitrypsin and hybrid molecules containing same
